tradmap

CSX Financials CSX Corporation

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 5.9% per year over the past 5 years.
  • Net income has grown slower than revenue (0.9% vs 5.9% per year).
  • Operating margin has contracted, at 32.1% in the latest year.
  • Free cash flow has declined 8.3% per year over the past 5 years.

Financial health

  • Total debt has grown in line with revenue (6.4% vs 5.9% per year).
  • Operating income covered interest expense 5.4× in the latest year.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 33.6% of earnings and 56.8% of free cash flow.
  • The dividend has grown 4.0% per year over the past 5 years.
Revenue & net income
$0 $7B $15B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 24% 48% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
0% 19% 37% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
$0 $2B $3B 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $5B $10B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$4B $707M $6B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $14.1B $2.9B 0.0% 32.1% 22.0% 6.6% $1.7B $670M
2024 $14.5B $3.5B 0.0% 36.1% 27.7% 8.1% $2.7B $933M
2023 $14.7B $3.7B 0.0% 37.5% 30.6% 8.7% $3.3B $1.4B
2022 $14.9B $4.1B 0.0% 40.1% 33.0% 9.9% $3.4B $1.9B
2021 $12.5B $3.8B 0.0% 44.7% 28.1% 9.3% $3.3B $2.2B
2020 $10.6B $2.8B 0.0% 41.2% 21.1% 6.9% $2.6B $3.1B
2019 $11.9B $3.3B 0.0% 41.6% 28.1% 8.7% $3.2B $958M
2018 $12.3B $3.3B 0.0% 39.7% 26.3% 9.0% $2.9B $858M
2017 $11.4B $5.5B 0.0% 32.6% 37.2% 15.3% $1.4B $401M
2016 $11.1B $1.7B 0.0% 30.8% 14.7% 4.8% $643M
2015 $2.0B 16.9% 5.7% $808M
2014 $1.9B 17.2% 5.8% $894M
2013 $1.9B 17.7% 5.9% $954M
2012 $1.9B 20.4% 6.1% $605M $9.8B
2011 $1.9B 21.6% 6.3% $1.2B $9.2B

Valuation over time

How the market has priced CSX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 16.2 32.4 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 3.3 6.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S
Dividend yield (%)
0.0 0.9 1.8 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
Dividend yield %

Frequently asked questions

Is CSX growing its revenue and profit?

Over the past 5 years, CSX Corporation's revenue has grown 5.9% per year, and net income grown 0.9% per year. These are computed facts, not advice.

How much debt does CSX have?

As of FY2025, CSX Corporation reported — of total debt against $670M of cash; operating income covered interest expense 5.4×.

What is CSX's profit margin?

In FY2025, gross margin was —, operating margin 32.1%, and net margin 20.5%.

What is CSX's P/E ratio?

As of Sep '26, CSX Corporation traded at a price-to-earnings ratio of about 31.4× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.